TMS and Pregnancy: Is It a Safe Treatment for Depression?

Depression during pregnancy is more common than many people realize. While pregnancy is often described as a joyful time, hormonal shifts, physical changes, and life stress can significantly affect mood. For some women, symptoms become severe enough to meet criteria for major depressive disorder (MDD).

Because untreated depression carries real risks for both mother and baby, treatment is important. At the same time, many pregnant patients worry about taking medication. This has led to growing interest in non-medication options, including transcranial magnetic stimulation (TMS) during pregnancy.

Understanding depression during pregnancy

Major depressive disorder is more than occasional sadness. It involves persistent low mood, loss of interest in activities, and difficulty functioning for at least two weeks.

During pregnancy, depression can be harder to recognize. Fatigue, sleep changes, and appetite shifts are common in pregnancy, but they can also be symptoms of depression.

Untreated depression during pregnancy has been linked to:

  • Poor prenatal care
  • Increased substance use
  • Higher stress levels
  • Preterm birth
  • Low birth weight
  • Increased risk of postpartum depression

Maternal mental health affects not only the mother’s wellbeing, but also fetal development and early bonding. Treating depression is about protecting both.

Symptoms of depression in pregnancy

Depression during pregnancy may include:

  • Persistent sadness or tearfulness
  • Loss of interest in activities
  • Feelings of guilt or hopelessness
  • Changes in sleep or appetite beyond typical pregnancy patterns
  • Difficulty concentrating
  • Thoughts of self-harm

When symptoms interfere with daily life or feel overwhelming, professional support is important.

Why some patients seek alternatives to medication

Antidepressants are widely studied in pregnancy and are often considered when depression is moderate to severe. Most research suggests that commonly prescribed SSRIs are not associated with a significant increase in birth defects.

However, some newborns may experience temporary symptoms after birth, such as mild jitteriness, irritability, feeding difficulties, or brief breathing changes. These symptoms usually resolve within a few days. There may also be a small increase in the risk of a rare breathing condition.

Because of these concerns, some patients prefer to explore treatment options that do not involve medication exposure during pregnancy. This is where interest in TMS often begins.

What is TMS?

Transcranial magnetic stimulation (TMS) is a noninvasive treatment that uses gentle magnetic pulses to stimulate areas of the brain involved in mood regulation.

Benefits of TMS include:

  • Does not require anesthesia
  • Does not involve taking medication
  • Does not send medication through the bloodstream

TMS is cleared by the U.S. Food and Drug Administration (FDA) to treat major depressive disorder and treatment-resistant depression. While pregnancy-specific labeling is limited, research on TMS during pregnancy is growing.

TMS and pregnancy: how it works in practice

When TMS is used during pregnancy, clinicians take additional precautions to support maternal comfort and circulation. These may include:

  • Positioning patients slightly on their left side to support healthy blood flow
  • Monitoring blood pressure and overall comfort
  • Coordinating care with the patient’s obstetric provider

Because TMS works locally in the brain and does not circulate throughout the body, it avoids fetal exposure to medication, a key reason some pregnant patients consider it.

TMS and pregnancy: what does the research say?

Research on TMS and pregnancy is still developing, but the findings so far are reassuring.

In a small pilot study of pregnant women with major depressive disorder, 70% of participants experienced a significant response to treatment.

Studies have included small clinical trials, observational studies, and case reports. Overall, research has not shown a consistent increase in birth defects or a clear link to low birth weight. Reported newborn outcomes have generally been healthy, and early developmental follow-up has been encouraging.

At the same time, most studies have involved relatively small numbers of patients. Larger, long-term studies are still needed to strengthen conclusions.

When might TMS be considered during pregnancy?

TMS may be considered when:

  • Depression is moderate and not improving with therapy alone
  • A patient cannot tolerate antidepressants
  • A patient prefers to avoid medication during pregnancy
  • There is a history of medication non-response

Treatment decisions should always involve careful discussion between the patient, psychiatric provider, and obstetric team.

In summary

Depression during pregnancy carries meaningful risks for both mother and baby. While antidepressants remain an important and often appropriate treatment option, TMS and pregnancy represents a promising alternative for selected patients seeking a non-medication approach.

Current research suggests reassuring maternal and neonatal safety, though larger studies are still needed. As with all perinatal mental health decisions, treatment should be individualized — balancing symptom severity, patient preferences, and the risks of untreated depression.

Frequently asked questions

1. Is TMS safe during pregnancy?

Current research suggests TMS appears generally safe, though larger studies are still needed to confirm long-term outcomes.

2. Does TMS expose the baby to medication?

No. TMS is a noninvasive brain stimulation treatment and does not involve systemic drug exposure.

3. When is TMS considered during pregnancy?

It may be considered for moderate depression, medication intolerance, or when patients prefer non-pharmacologic treatment.

4. Is TMS safer than antidepressants?

Each option carries different risks and benefits. TMS avoids medication exposure but requires frequent clinic visits.

5. Does TMS require anesthesia like ECT?

No. TMS does not require anesthesia.

Key takeaways

  • Untreated depression during pregnancy carries real maternal and fetal risks.
  • TMS offers a noninvasive, non-medication treatment option.
  • Available research suggests reassuring neonatal safety data.
  • Treatment decisions should involve shared decision-making.
  • Larger studies are needed to strengthen long-term safety conclusions.

Looking for TMS treatment near you?

Pacific Mind Health offers transcranial magnetic stimulation (TMS) for depression, OCD, and other mental health conditions. Our experienced clinicians provide compassionate, evidence-based care to help you feel better.

Ready to take the next step? Schedule a free consultation today to see if TMS is right for you.

Joshua Flatow 4
Medical Reviewer:

Table of Contents